UK’s Joint Venture Bridging Academia and Industry is Ready for Kick Off
Apollo Therapeutics is a UK-based joint venture bridging academia and industry to drive the translation of university research.…
Apollo Therapeutics is a UK-based joint venture bridging academia and industry to drive the translation of university research.…
GSK announced Phase III results for dolutegravir, which could reduce triple HIV therapy down to…
Neurokinins are under investigation for a range of conditions from women's health to pain. NeRRe…
There is currently no vaccine for the fast-growing disease in the US, & treatments cost…
Update (01/12/2016): The HVTN 702 trial has been started, making it the first HIV vaccine…
GSK is banishing concerns about its health with a BLA submission for Shingrix, which has…
A new transparency study has identified Sanofi, Novartis and GSK as the companies that keep the…
Gilead has long been the leader in HIV treatments, but GlaxoSmithKline's CEO revealed to the…
The second-ever gene therapy to get European approval finally has a price tag. It will…
GSK and Verily Life Sciences are creating a new company together, Galvani Bioelectronics. Along with…
GSK and Avalon Ventures are having success with the Biotechs created under their collaboration. Sitari Pharmaceuticals…
GSK has started a phase II trial for inflammatory hand osteoarthritis, with a candidate originally from…